Phototherapy and photochemotherapy;Fototerapia y fotoquimioterapia

Actas Dermo-Sifiliograficas

Volumn 95, Issue 5, 2004, Pages 259-284

  Carrascosa, José Manuel ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

Photobiology; Phototherapy; PUVA; Therapeutics; UVB

Indexed keywords

ALPHA INTERFERON; BERGAPTEN; BEXAROTENE; CORTICOSTEROID; CYCLOSPORIN A; DITHRANOL DERIVATIVE; EMOLLIENT AGENT; ETRETIN; INTERLEUKIN 10; METHOTREXATE; METHOXSALEN; PHENYLALANINE; PSORALEN; RETINOID; TAZAROTENE; VITAMIN D DERIVATIVE;

ALOPECIA AREATA; ATOPIC DERMATITIS; BALNEOTHERAPY; CUTANEOUS T CELL LYMPHOMA; EXCIMER LASER; GASTROINTESTINAL SYMPTOM; HUMAN; LICHEN PLANUS; LUPUS ERYTHEMATOSUS; MASTOCYTOSIS; PHOTOCHEMOTHERAPY; PHOTOTHERAPY; PHOTOTOXICITY; PIGMENT DISORDER; PROPIONIBACTERIUM ACNES; PRURIGO; PRURITUS; PSORIASIS; PUVA; REMISSION; REVIEW; SCLERODERMA; SKIN LYMPHOMA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION; URTICARIA PIGMENTOSA; VITILIGO;

EID: 3242813666     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-7310(04)76817-9     Document Type: Review

References (241)

1. Abel EA. Phototherapy: UVB and PUVA. Cutis 1999;64:339-42.
2. Abel EA. Phototherapy. En: Thiers BH, Lebwohl MG, Zanolli M, editors. Psoriasis: Dermatology Clinic. Philadelphia: WB Saunders, 1995; p. 841-9.
3. Piskin G, Koomen CW, Picavet D, Bos JD, Teunissen MB. Ultraviolet-B irradiation decreases IFN-gamma and increases IL-4 expression in psoriatic lesional skin in situ and in cultured dermal T cells derived from these lesions. J Exp Dermatol 2003;12:172-80.
4. El-Ghorr AA, Norval M. Biological effects of narrow-band (311 nm TL-01) UVB irradiation. A review. J Photochem Photobiol B 1997;38:99-106.
5. Jones CD, Gukian M, El-Ghorr AA, Gibbs NK, Norval M. Effects of phototherapy on the production of cytokines by peripheral blood mononuclear cells and on systemic antibody responses in patients with psoriasis. Photodermatol Photoimmunol Photomed 1996;12:204-10.
6. Jekler J, Diffey B, Larko O. Ultraviolet radiation dosymetry in phototherapy for atopic dermatitis. J Am Acad Dermatol 1990;23:49-51.
7. Boonstra HE, Van Weelden H, Toonstra J, Van Vloten WA. Polymorphous light eruption: A clinical, photobiologic, and follow-up study of 110 patients. J Am Acad Dermatol 2000;42:199-207.
8. Man I, Dawe I, Ferguson J. Artificial hardening for polymorphic light eruption: practical points from ten years' experience. Photodermatol Photoimmunol Photomed 1999;15:96-9.
9. Zackheim HS. Treatment of mycosis fungoides/sezary syndrome: the University of California, San Francisco approach. Int J Dermatol 2003;42:53-6.
10. Ortel B, Hönigsmann H. Phototherapy and photochemotherapy. En: Hawk JLM, editor. Photodermatology: Chapman & Hall, 1998; p. 223-40.
11. Wulf HC, Bech-Thomsen N. A UVB phtottherapy protocol with very low dose increments as a treatment of atopic dermatitis. Photodermatol Photoimmunol Photomed 1998;14:1-6.
12. Selvaag E, Caspersen L, Bech-Thomsen N, Olivarius FF, Wulf HC. Optimized UVB treatment of psoriasis: a controlled, left-right comparison trial. JEADV 2000;14:19-21.
13. Almagro M, Del Pozo J, Fonseca E. Protocolos de fototerapia en psoriasis. Piel 1999;14:163-9.
14. Stern RS, Amstrong RB, Anderson TF, et al. Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study. J Am Acad Dermatol 1986;15:546-52.
15. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Cancer 1994;73:2759-64.
16. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981;76:359-62.
17. Fisher T. UV-light treatment of psoriasis. Acta Derm Venereol (Stockh) 1976;56:473-9.
18. Van Weelden H, Van der Leun JC. Improving the effectiveness of phototherapy for psoriasis. Br J Dermatol 1984;111:484 (abs).
19. Van der Leun JC, Van Weelden H. UVB phototherapy; principles, radiation sources, regimens. Curr Probl Dermatol 1986;15:39-51.
20. Larkö O, Treatment of psoriasis with a new UVB-lamp. Acta Derm Venereol (Stockh) 1989;69:357-9.
21. Green C, Ferguson J, Lakshmipathi T, Johnson BE. 311 nm UVB phototerapy: an effective treatment for psoriasis. Br J Dermatol 1988;119:691-6.
22. Picot E, Meunier L, Picot-Debeze MC, Peyron JL, Meynadier J. Treatment of psoriasis with a 311-nm UVB lamp. Br J Dermatol 1992;127:509-12.
23. Dawe RS. A quantitative review of studies comparing the efficacy of narrow-band and broad band ultraviolet B for psoriasis. Br J Dermatol 2003;149:655-80.
24. Cameron H, Yule S, Moseley H, Dawe RS, Ferguson J. Taking treatment to the patient: development of a home TL-01 ultraviolet B phototherapy service. Br J Dermatol 2002;147:957-635.
25. Markham T, Rogers S, Collins P. Narrowband UV-B (TL-01) phototherapy vs oral 8-methoxypsoralen psoralen-UV-A for the treatment of chronic plaque psoriasis. Arch Dermatol 2003;139:325-8.
26. Van Weelden H, Baart de la Faille H, Young E, Van der Leun. Comparison of narrow-band UV-B phototherapy and PUVA photochemotherapy in the treatment of psoriasis. Acta Derm Venereol (Stockh) 1990;70:212-5.
27. Gordon PM, Diffey L, Matthews JNS, Farr PM. A randomized comparison of narrow-band TL-01 and PUVA photochemotherapy for psoriasis. J Am Acad Dermatol 1999;41:728-32.
28. Tanew A, Radakovic-Fijan S, Schemper M, Hönigsmann H. Narrow-band UV-B phototherapy vs photochemotherapy in the treatment of chronic plaque-type psoriasis. A paired comparison study. Arch Dermatol 1999;135: 519-24.
29. Dawe RS, Cameron H, Yule S, et al. A comparison of TL01 UVB phototherapy and bath-PUVA for chronic plaque psoriasis [abstract]. Br J Dermatol 2000;143 (Suppl 57):15.
30. Dawe RS, Cameron H, Yule S, et al. A randomized controlled trial of narrowband ultraviolet B vs bath-psoralen plus ultraviolet A photochemotherapy for psoriasis. Br J Dermatol 2003;148:1194-204.
31. Carrascosa JM, X Bigatà. UVBterapia de banda estrecha: experiencia en la práctica clínica y factores predictivos de respuesta. Actas Dermosifiliogr 2000;91:555-62.
32. Carrascosa JM, Mangas C, Ferrándiz C. UVB terapia de banda estrecha en el tratamiento de la psoriasis: experiencia clínica 1995-2001. Actas Dermosifiliogr 2003;94 (Supl 1):66.
33. George SA, Bilsland DJ, Johnson BE, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phototherapy for chronic severe adult atopic dermatitis. Br J Dermatol 1993;128:49-56.
34. Collins P, Ferguson J. Narrow-band (TL-01) UVB air-conditioned phothotherapy for atopic eczema in children. Br J Dermatol 1995;133:653-67.
35. Hudson-Peacock MJ, Diffey BL, Farr PM. Narrow-band UVB phototherapy for severe atopic dermatitis. Br J Dermatol 1996;135:330-45.
36. Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, Kerscher M. Phototherapy for atopic eczema with narrow-band UVB. J Am Acad Dermatol 1999;40:995-7.
37. Der-Petrossian M, Seeber A, Honigsmann H, Tanew A. Half-side comparison study on the efficacy of 8-methoxypsoralen bath-PUVA versus narrow-band ultraviolet B phototherapy in patients with severe chronic atopic dermatitis. Br J Dermatol 2000;142:39-43.
38. Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomized controlled trial. Lancet 2001;357:2012-6.
39. Njoo MD, Westerhof W, Bos JD, Bossuyt PMM. The development of guidelines for the treatment of vitiligo. Arch Dermatol 1999;135:1514-21.
40. Natta R, Somsak T, Wisuttida T, Laor L. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians. J Am Acad Dermatol 2003;49:473-6.
41. Westerhof W, Nieuweboer-Krobotova L. Treatment of vitiligo with UV-B radiation vs topical psoralen plus UVA. Arch Dermatol 1997;133:1525-8.
42. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001;44:999-1003.
43. Zanolli MD, Feldman SR, Clark AR, Fleischer AB. Phototherapy. Treatment protocols for psoriasis and other phototherapy responsive dermatoses. Norton: The Partenon Publishing Group, 1974; p. 73-5.
44. Carrascosa JM, Sabat M, Ferrándiz C. Terapia combinada con UVBterapia de banda estrecha y calcipotriol en el vitiligo. Experiencia en la práctica clínica. Med Cutan Iber Lat Am 2002;30:293-8.
45. Carrascosa JM, Mangas C, Ferrándiz C. Terapia UVB de banda estrecha en prurigo nodular. Actas Dermosifiliogr 2003;94:294-9.
46. Hofer A, Cerroni L, Kerl H, Wolf P. Narrowband (311nm) UVB therapy for small plaque psrapsoriasis and early-stage mycosis fungoides. Arch Dermatol 1999;135:1377-80.
47. Clark C, Dawe R, Evans A, Lowe G, Ferguson J. Narrow-band TL-01 phototherapy for patch-stage mycosis fungoides. Arch Dermatol 2000;136:748-52.
48. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrow-band UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002;47:191-7.
49. Diederen PV, Van Weelden H, Sanders CJ, Toonstra J, Van Vloten WA. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003;48:215-9.
50. Collins P, Ferguson J. Narrow-band UVB (TL-01) phototherapy: an effective preventative treatment for the photodermatoses. Br J Dermatol 1995;132:956-63.
51. Pirkhammer D, Seeber A, Hoonigsmann Tanew A. Narrow-band ultraviolet B (TL-01) phototherapy is an effective and sale treatment option for patients with severe seborrhoeic dermatitis. Br J Dermatol 2000;143:964-8.
52. Bayramgurler D, Apaydin R, Cetiner D, Zincirci C. Narrow-band ultraviolet B phototherapy for acquired perforating dermatosis. Australas J Dermatol 2003;44:76-8.
53. Grundmann-Kollmann M, Martin H, Ludwig R, et al. Narrowband UV-B phototherapy in the treatment of cutaneous graft versus host disease. Transplantation 2002;74:1631-4.
54. Baldo A, Sammarco E, Plaitano R, Martinelli V. Narrow-band (TL-01) ultraviolet B phototherapy for pruritus in polycythaemia vera. Br J Dermatol 2002;147:979-81.
55. Reed G. Pruritic folliculitis of pregnancy treated with narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1999;141:177.
56. Valkova S, Trashlieva M, Christova P. UVB Phototherapy for Pityriasis rosea. JEADV 2004;18:111-2.
57. Yashar SS, Gielczyk R, Scherschun L, Lim HW. Narrow-band ultraviolet B treatment for vitiligo, pruritus, and inflammatory dermatoses. Photodermatol Photoimmunol Photomed 2003;19:164-8.
58. Picot E, Picot-Dezebe MC, Meunier L, Peyron JL, Meynadier J. La phototherapie UVB à spectre étroit (lampes phillips TL01) dans le psoriasis. Ann Dermatol Venereol 1992;119:639-42.
59. Hofer A, Fink-Puches R, Kerl H, Wolf P. Comparison of phototherapy with near vs. far erythemogenic doses of narrow-band ultraviolet B in patients with psoriasis. Br J Dermatol 1998;138:96-100.
60. Van Weelden H, De la Faille HB, Young E, Van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988;119:11-9.
61. Alora MBT, Taylor CR. Narrow-band (311 nm) UVB phototherapy: an audit of the first year's experience at the Massachusetts General Hospital. Photodermatol Photoimmunol Photomed 1997;13:82-4.
62. Walters IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythematogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1999;40:893-900.
63. Dawe RS, Wainwright NJ, Cameron H, Ferguson J. Narrow-band (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment? Br J Dermatol 1998;138:833-9.
64. Halasz CL. Narrowband UVB phototherapy for psoriasis: results with fixed increments by skin type (as opposed to percentage increments). Photodermatol Photoimmunol Photomed 1999;15:81-4.
65. Zanolli MD, Feldman SR, Clark AR, Fleisher AB. Phototherapy. Treatment protocols for psoriasis and other phototherapy responsive dermatoses. Carnforth: Parthernon, 2000; p. 17-21.
66. Leenutaphong V, Nimkulrat P, Sudtim S. Comparison of phototherapy two times and four times a week with low doses of narrow-band ultraviolet B in Asian patients with psoriasis. Photodermatol Photoimmunol Photomed 2000;16:202-6.
67. Cameron H, Dawe RS, Yule S, Murphy J, Ibbotson SH, Ferguson J. A randomized, observer-blinded trial of twice vs. three times weekly narrowband ultraviolet B phototherapy for chronic plaque psoriasis. Br J Dermatol 2002;147:973-8.
68. Calzavara-Pinton PG, Zane C, Candiago E, Facchetti F. Blisters on psoriatic lesions treated with TL-01 lamps. Dermatology 2000;200:115-9.
69. Gibbs NK, Traynor NJ, MacKie RM, Campbell I, Johnson BE, Ferguson J. The phototumorigenic potential of broad-band (270-350 nm) and narrow-band (311-313 nm) phototherapy sources cannot be predicted by their edematogenic potential in hairless mouse skin. J Invest Dermatol 1995;104:359-63.
70. Tzung TY, Runger TM. Assessment of DNA damage induced by broadband and narrowband UVB in cultured lymphoblasts and keratinocytes using the comet assay. Photochem Photobiol 1998;67:647-50.
71. De Gruijl FR. Long-term side effects and carcinogenesis risk in UVB therapy. En: Hönigsmann H, Jori G, Young AR, editors. The Fundamental Bases of Phototherapy. Milan: OEMF SpA, 1996; p. 153-70.
72. Cooper SM, Turner GDH, Hollowood K, Gatter K, Hatton C, Gray D. Factors affecting the choice of a ceiling on the number of exposures with TL01 ultraviolet B phototherapy. Br J Dermatol 2003;149:419-46.
73. Midelfart K, Stenvold SE, Volden G. Combined UVB and UVA phototherapy of atopic eczema. Dermatologica 1985;171:95-8.
74. Parrish JA, Fitzpatrick TB, Tannebaum L, Pathak MA. Photochemotherapy of psoriasis with oral methoxalen and longwave ultraviolet light. N Engl J Med 1974;291:1207-11.
75. Melski JW, Tannebaum L, Parrish JA, et al. Oral methoxalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial. J Invest Dermatol 1977;68:328-35.
76. Morison WL, Wimberly J, Parrish JA. Abnormal lymphocyte function following long-term PUVA therapy for psoriasis. Br J Dermatol 1983;108:445-50.
77. Laing T, Richardson B, Toth M. Ultraviolet light and 8-methoxypsoralen inhibit expression of endothelial adhesion molecules. J Rheumatol 1995;22:2126-31.
78. Beissert S, Schwarz T. Role of immunomodulation in disease responsive to phototherapy. Methods 2002;28:138-44.
79. Grundmann-Kollmann M, Behrens S, Peter RU, Kerscher M. Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA-bath versus PUVA-cream therapy. Photodermatol Photoimmunol Photomed 1999;15:87-9.
80. Behrens S, Von Kobyletzki G, Gruss C, Reuther T, Altmeyer P, Kerscher M. PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and soles. Photodermatol Photoimmunol Photomed 1999;15:47-51.
81. Herrmann JJ, Roenigk HH, Hönigsmann H. Ultraviolet radiation for treatment od cutaneous T-cell lymphoma. Hematol Oncol Clin North Am 1995;9:1077-88.
82. Honigsmann H, Brenner W, Rauschmeier W, et al. Photochemotherapy for cutaneous T cell lymphoma. J Am Acad Dermatol 1984;10:238-45.
83. Oguz O, Engin B, Aydemir EH. The influence of psoralen + ultraviolet A treatment on the duration of remission and prognosis in mycosis fungoides. JEADV 2003;17:483-5.
84. Siegel RS, Pandolfino T, Guitart J, Rosen S, Kusel TM. Primary cutaneous T-cell lymphoma: review and current concepts. J Clin Oncol 2000;18:2908-25.
85. Halder RM, Young C. New and emerging therapies for vitiligo. Dermatol Clin 2000;18:79.
86. Kovacs SO, Vitiligo. J Am Acad Dermatol 1998;38:647-66.
87. Shaffrali FCG, Gawkrodger DJ. Management of vitiligo. Clin Exp Dermatol 2000;25:575-9.
88. Kwok YK, Anstey AV, Hawk JL. Psoralen photochemotherapy (PUVA) is only moderately effective in widespread vitiligo: a 10-year retrospective study. Clin Exp Dermatol 2002;27:104-10.
89. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for vitiligo. J Am Acad Dermatol 1996;35:620-6.
90. Sheehan MP, Atherton DJ, Norris P. Oral psoralen photochemotherapy in severe childhood atopic eczema: an update. Br J Dermatol 1993;129:431-6.
91. Uetsu N, Horio T. Treatment of persistent severe atopic dermatitis in 113 Japanese patients with oral psoralen photo-chemotherapy. J Dermatol 2003;30:450-7.
92. Whitmont KJ, Cooper AJ. PUVA treatment of alopecia areata totalis and universalis: a retrospective study. Australas J Dermatol 2003;44:106-9.
93. Ling TC, Gibbs NK, Rhodes LE. Treatment of polymorphic light eruption. Photodermatol Photoimmunol Photomed 2003;19:217-27.
94. Stratigos AJ, Antoniou C, Katsambas AD. Polymorphous light eruption. JEADV 2002;16:193-206.
95. Cianchini G, Colonna L, Bergamo F, Angelo C, Puddu P. Efficacy of Psoralen-UV-A therapy in 3 cases of Schnitzler syndrome. Arch Dermatol 2001;137:1536-7.
96. Furlong T, Leisenring W, Storb R, et al. Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease. Biol Blood Marrow Transplant 2002;8:206-12.
97. Leiter U, Kaskel P, Krahn G, et al. Psoralen plus ultraviolet-A-bath photochemotherapy as an adjunct treatment modality in cutaneous chronic graft versus host disease. Photodermatol Photoimmunol Photomed 2002;18:183-90.
98. De Rie MA, Sommer A, Hoekzema R, Neumann HA, Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002;147:743-7.
99. Adachi Y, Iba S, Horio T. Succesful treatment of lichen myxoedematosus with PUVA photochemotherapy. Photodermatol Photoimmunol Photomed 2000;16:229-31.
100. Remling R, Schnopp C, Schmidt T, Hein R, Ring J, Abeck D, Keratosis lichenoides chronica. Bath PUVA therapy-Hautarzt 2002;53:550-3.
101. Goodkin R, Bernhard JD, Repeated PUVA treatment of aquagenic pruritus. Clin Exp Dermatol 2002;27:164-5.
102. González E. PUVA for psoriasis. Dermatol Clin 1995;13: 851-66.
103. Stern RS, Momtaz K. Skin typing for assessment of skin cancer and acute response to UVA and oral methoxalen photochemotherapy. Arch Dermatol 1985;20:869-73.
104. Sakuntabhai A, Sharpe GR, Farr PM. Response of psoriasis to twice weekly PUVA. Br J Dermatol 1993;128:166-71.
105. Hesse G, Wichmann-Hesse AC, Bercher M. PUVA therapy with low UVA dose. Z Hautarz 1987;62:927-30.
106. Collins P, Wainwright NJ, Amorin I, Lakshmipathi T, Ferguson J. 8-MOP PUVA for psoriasis: a comparison of minimal phototoxic dose-based regimen with a skin-type approach. Br J Dermatol 1996;135:248-54.
107. Fisher T, Alsins J. Treatment of psoriasis with trioxalen baths and dysprosium lamps. Acta Derm Venereol Suppl (Stockh) 1976;56:383-90.
108. Halpern SM, Anstey AV, Dawe RS, Diffey BL, Farr PM, Ferguson J. Guidelines for topical PUVA: a report of a workshop of the Brititsh Phtotodermatology Group. Br J Dermatol 2000;142:22-31.
109. Collins P, Rogers S. Bath-water delivery of 8-methoxypsoralen therapy in psoriasis. Clin Exp Dermatol 1991;16:246-55.
110. Gomez MI, Pérez B, Harto A. 8-MOP bath PUVA in the treatment of psoriasis: clinical results in 42 patients. J Dermatol Treat 1996;7:11-2.
111. Hannuksela M, Karvonen J. Trioxalen bath plus UVA effective and safe in the treatment of psoriasis. Br J Dermatol 1978;99:703-7.
112. Gruss C, Behrens S, Reuther T, Husebo L. Kinetics of photosensivity in bath-PUVA photochemotherapy. J Am Acad Dermatol 1998;39:443-6.
113. Lüftl M, Degitz K, Plewig G, Röcken M. Psoralen path plus UVA-therapy. Arch Dermatol 1997;133:1597-603.
114. Thomas SE. Plasma levels of 8-methoxipsoralen following oral or bath-water treatment. Br J Dermatol 1982;106:199.
115. Calzavara-Pinton PG, Zane C, Carlino A, De Panfilis G. Bath-5-methoxypsoralen-UVA therapy for psoriasis. J Am Acad Dermatol 1997;36:945-9.
116. Stege H, Berneburg M, Ruzicka T, Krutmann J. Crème-PUVA photochemotherapie. Der Hautarzt 1997;48:89-93.
117. Murray D, Corbett MF, Warin AP. A controlled trial of photochemotherapy for persistent palmoplantar pustulosis. Br J Dermatol 1980;102:659-63.
118. Lassus A, Lauharante J, Eskelinen A. The effect of etretinate compared with different regimens of PUVA in the treatment of persistent palmoplantar pustulosis. Br J Dermatol 1985;112:544-9.
119. Layton AM, Sheehan-Dare R, Cunliffe WJ. A double-bind placebo-controlled trial of topical PUVA in persistent palmoplantar pustulosis. Br J Dermatol 1991;124:581-4.
120. Neild VS, Scott LV. Plasma levels of 8-methoxypsoralen in psoriatic patients receiving topical 8-methoxypsoralen. Br J Dermatol 1982;106:199-203.
121. Hallman CP, Koo JYM, Omohundro C, Lee J. Plasma levels of 8-methoxypsoralen after topical paint PUVA of nonpalmoplantar psoriatic skin. J Am Acad Dermatol 1994;31:273-5.
122. Geschnait F, Wolff K, Honigsmann H. Longterm photochemotherapy; histopathological and immunofluorescence observations in 243 patients. Br J Dermatol 1980;103:11-22.
123. Pariser DM, Wyles RJ. Toxic hepatitis from oral methoxsalen photochemotherapy (PUVA). J Am Acad Dermatol 1980;3:248-50.
124. Martin S, Petitpain N, Trechot N, Barbaud N, Schmutz JL. 8-Methoxypsoralen-induced dysosmia Photodermatol Photoimmunol Photomed 2003;114:213-4.
125. Souetre E, Salvati E, Belugou JL, Krebs B, Darcourt G. 5-Methoxypsoralen increases evening sleepiness in humans: possible involvement of the melatonin secretion. Eur J Clin Pharmacol 1989;36:91-2.
126. Dowdy MJ, Nigra TP, Barth WF. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum 1989;32:343-6.
127. Berg M. Drug fever caused by 8-methoxypsoralen. Photodermatol 1989;6:149-50.
128. Takashima A, Yamamoto K, Kimura S. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA. Br J Dermatol 1991;124:37-42.
129. Stern S, Lange R. Non-melanoma skin cancer occurring in patients treated with PUVA five to ten years after first treatment. J Invest Dermatol 1988;91:120-4.
130. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol 2003;121:252-8.
131. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxalen (psoralen) and ultraviolet A radiation (PUVA). N Engl J Med 1997;336:1041-5.
132. Honigsmann H. Phototherapy of psoriasis. Clin Exp Dermatol 2001;26:343-50.
133. Stern RS. Actinic degeneration and pigmentary change in association with psoralen and UVA treatment: a 20-year prospective study. J Am Acad Dermatol 2003;48:61-7.
134. Lerman S, Megaw J, Willis I. Potential ocular complications from PUVA therapy and their prevention. J Invest Dermatol 1980;74:197-9.
135. Hammershoy O, Jessen F. A retrospective study of cataract formation in 96 patients treated with PUVA. Acta Derm Venereol (Stockh) 1982;62:444-6.
136. Morison WL, Parrish JA, Woehler M. Influence of PUVA and UVB radiation on delayed hypersensitivity in the guinea pig. J Invest Dermatol 1982;79:205-8.
137. British Photodermatology Group. British Photodermatology Group guidelines for PUVA. Br J Dermatol 1994;130:246-55.
138. Drake LA, Ceilley RI, Corner W, et al. Guidelines of care for phototherapy and photochemotherapy. J Am Acad Dermatol Venereol 1994;31:643-8.
139. Carrascosa JM, Lezcano C, Quiñones C, Borrás A, Bonafon X, Costa J. Tema de la semana: Fotosensibilidad por fármacos: fototoxia y fotoalergia. 7 DM 2003;569:814.
140. Eguino P, Gardeazabal J, Díaz-Pérez JL. Urticaria solar. Piel 2003;18:481-7.
141. Wlaschek M, Briviba K, Stricklin GP, Sies H, Scharfetter-Kochanek K. Singlet oxygen may mediate the ultraviolet A-induced synthesis of interstitial collagenase. J Invest Dermatol 1995;104:194-8.
142. Morita A, Werfel T, Stege H, et al. Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med 1997;186:1763-8.
143. Grabbe J, Welker P, Humke S, Schöpf E, Henz BM, Krutmann J. High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema. J Invest Dermatol 1996;107:419-23.
144. Kerscher M, Dirschka T, Volkenand M. Treatment of localised scleroderma by UVA1 phototherapy. Lancet 1995;346:1166.
145. Dawe RS. Ultraviolet A1 phototherapy. Br J Dermatol 2003;148:626-37.
146. Legat FJ, Hofer A, Bravek E, Quehenberger F, Kerl H, Wolf P. Narrowband UVB-B vs medium-dose UV-A1 phototherapy in chronic atopic dermatitis. Arch Dermatol 2003;139:223-4.
147. Polderman MC, Huizinga TW, Le Cessie S, Pavel S. UVA-1 cold light treatment of SLE: a double blind, placebo controlled crossover trial. Ann Rheum Dis 2001;60:112-5.
148. Rücker BU, Häberle M, Koch HU. Ultraviolet light hardening in polymorphous light eruption - a controlled study comparing difference emission sprectra. Photodermatol Photoimmunol Photomed 1991;8:73-8.
149. Zane C, Leali C, Airo P. UVA1 therapy of widespread plaquetype, nodular, and erythrodermic mycosis fungoides. J Am Acad Dermatol 2001;44:629-33.
150. Plettenberg H, Stege H, Megahed M. UVA-1 phototherapy versus PUVA photochemotherapy in the treatment of patients with cutaneous T cell lymphoma [abstract]. Photodermatol Photoimmunol Photomed 2001;17:87.
151. Gobello T, Mazzanti C, Sordi D, et al. Medium- versus high-dose ultraviolet A1 therapy for urticaria pigmentosa: a pilot study. J Am Acad Dermatol 2003;49:679-84.
152. Stege H, Budde M, Kurten V. Induction of apoptosis in skin infiltrating mast cells by high-dose ultraviolet A1 radiation phototherapy in patients with urticaria pigmentosa. Lancet 1999;112:347-64.
153. Calzavara Pinton P, Porta F, Izzi T, et al. Prospects for ultraviolet A1 phototherapy as a treatment for chronic cutaneous graft-versus-host disease. Haematologica 2003;88:1169-75.
154. Kreuter A, Gambichler T, Avermaete A, et al. Low-dose ultraviolet A1 phototherapy for extragenital lichen sclerosus: results of a preliminary study. J Am Acad Dermatol 2002;46:251-5.
155. De Rie MA, Enomoto DN, de Viles HJ, Bos JD. Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method. Dermatology 2003;207:298-301.
156. Dover JS, McEvoy MT, Rosen CF, Arndt KA, Stern RS. Are topical corticosteroids useful in phototherapy for psoriasis? J Am Acad Dermatol 1989;20(5 pt 1):748-54.
157. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol 1999;41:51-9.
158. Schmoll M, Henseler T, Christophers E. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis. Br J Dermatol 1978;99:693-702.
159. Morison WL, Parrish JA, Fitzpatrick TB. Controlled study of PUVA and adjunctive topical therapy in the management of psoriasis. Br J Dermatol 1978;98:125-32.
160. LeVine MJ, Parrish JA. The effect of topical fluocinolone ointment on phototherapy of psoriasis. J Invest Dermatol 1989;78:157-62.
161. Westerhof W, Nieuweboer-Krobotoa L, Mulder PG, Glazenburg EJ. Left-right comparison study of the combination of fluticasone propionate and UVA vs either fluticasone propionate or UVA alone for long-term treatment of vitiligo. Arch Dermatol 1999;135:1061-6.
162. Farber EM, Harris DR. Hospital treatment of psoriasis: A modified anthralin program. Arch Dermatol 1970;101:381-9.
163. Cripps DJ, Lowe NJ. Photochemotherapy of psoriasis remission times: psoralens and UVA and combined phothchemotherapy with anthralin. Clin Exp Dermatol 1979;4:477-83.
164. Paramsothy Y, Collins M, Lawrence CM. Effect of UVB therapy and a coal tar bath on short contact dithranol treatment for psoriasis. Br J Dermatol 1988;118:783-9.
165. Lebwohl M, Berman B, France DS. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: Assessment of efficacy. J Am Acad Dermatol 1985;13:780-5.
166. Karvonen J, Kokkonen EL, Ruotsalainen E. 311 nm UVB lamps in the treatment of psoriasis with the Ingram regimen. Acta Derm Venereol 1989;69:82-5.
167. Storbeck K, Holzle E, Schurer M. Narrow-band UVB (311 nm) versus conventional broad-band UVB with and without dithranol in phototherapy for psoriasis. J Am Acad Dermatol 1993;28:227-31.
168. Willis I, Harris RD. Resistant psoriasis: combined methoxalen-anthralin therapy. Arch Dermatol 1973;107:358-62.
169. López-Escobar M, Gómez S, Olivo del Valle M, Pérez N. Comparación entre terapia con PUVA y régimen de Goeckerman en el tratamiento de la psoriasis. Actas Dermosifiliogr 2004;95:32-7.
170. Silverman A, Menter A, Hairston JL. Alquitranes y antralinas. En: Lebwohl M, Zanolli M, editores. Psoriasis (ed. esp.). Madrid: Mc Graw-Hill, 1996; p. 893-912.
171. Rim JH, Choe YB, Youn JI. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients. Photodermatol Photoimmunol Photomed 2002;18:131-4.
172. Woo WK, McKenna KE. Combination TL-01 ultraviolet B phototherapy and topical calcipotriol for psoriasis: a prospective randomized placebo-controlled clinical trial. Br J Dermatol 2003;149:146-50.
173. Kerscher M, Plewig G, Lehmann P. Combination phototherapy of psoriasis with calcipotriol and narrow-band UVB [letter]. Lancet 1993;342:923.
174. Hofmann UB, Eggert AA, Brocker EB, Goebeler M. Calcitriol vs. dithranol in combination with narrow-band ultraviolet B (311 nm) in psoriasis. Br J Dermatol 2003;148:779-83.
175. Schiener R, Behrens-Williams SC, Pillekamp H, Kaskel P, Peter RU, Kerscher M. Calcipotriol vs tazarotene as combination therapy with narrowband ultraviolet B (311 nm): efficacy in patients with severe psoriasis. Br J Dermatol 2000;143:1275-8.
176. Speight EL, Farr PM. Calcipotriol improves the response of psoriasis to PUVA. Br J Dermatol 1994;130:79-82.
177. Frappaz A, Thivolet J. Calcipotriol in combination with PUVA: a randomized double-blind placebo study in severe psoriasis. Eur J Dermatol 1993;3:351-4.
178. Tzaneva S, Honigsmann H, Tanew A, Seeber A. A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis. Br J Dermatol 2002;147:748-53.
179. Mc Kenna KE, Stern RS. Photosensitivity associated with combined UVB and calcipotriene therapy. Arch Dermatol 1995;131:1305-7.
180. Lebwohl M, Quijije J, Gilliard J, Rollin T, Watts O. Topical calcitriol is degraded by ultraviolet light. J Invest Dermatol 2003;121:594-5.
181. Dogra S, Parsad D. Combination of narrowband UV-B and topical calcipotriene in vitiligo. Arch Dermatol 2003;139:393.
182. Katsambas A, Stefanaki C. Disorders of pigmentation: unapproved treatments. Clin Dermatol 2002;20:649-59.
183. Baysal V, Yildirim M, Erel A, Kesici D. Is the combination of calcipotriol and PUVA effective in vitiligo? JEADV 2003;17:299-302.
184. Behrens-Williams SC, Kraus D, Reuther T, Kerscher MJ. Do we alter ultraviolet sensitivity in vivo with stratum corneum rehydration? A pilot study and review of the literature. Br J Dermatol 2002;146:280-4.
185. Lebwohl M, Martínez J, Weber P, DeLuca R. Effects of topical preparations on erythemogenicity of UVB: implications for psoriasis therapy. J Am Acad Dermatol 1995;32: 469-74.
186. Brualla DA, Sánchez-Reñaga M, Massana J, Molinero J, Ojeda R, Umbert P. Optimización de la fototerapia UVB 311 nm con ácido oleico. Actas Dermosifiliogr 2003;94 (Supl 1):66-7.
187. George SA, Bilsland DJ, Wainwright NJ, Ferguson J. Failure of coconut oil to accelerate psoriasis clearance in narrow-band UVB phototherapy or photochemotherapy. Br J Dermatol 1993;128:301-5.
188. Fetil E, Ozka S, Soyal MC, Ilknur T, Erdem Y, Gunes AT. Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB. Eur J Dermatol 2002;12:154-6.
189. Ludwig P, Petrich K, Schowe T, Diezel W. Inhibition of eicosanoid formation in human polymorphonuclear leukocytes by high concentrations of magnesium ions. Biol Chem Hoppe-Seyler 1995;376:739-44.
190. Behrens S, Grundmann-Kollmann M, Schiener R, Peter RU, Kerscher M. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel. J Am Acad Dermatol 2000;42:493-5.
191. Koo JY. Tazarotene in combination with phototherapy. J Am Acad Dermatol 1998;39:144-8.
192. Hecker D, Worsley J, Yueh G, Kuroda K, Lebwohl M. Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol 1999;41:927-30.
193. Schallreuter KU, Moore J, Behrens-Williams S, Panske A, Harari M. Rapid initiation of repigmentation in vitiligo with Dead Sea climatotherapy in combination with pseudocatalase (PC-KUS). Int J Dermatol 2002;41:482-7.
194. Patel DC, Evans AV, Hawk JL. Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study. Clin Exp Dermatol 2003;28:562-3.
195. Zanolli M. Phototherapy treatment of psoriasis today. J Am Acad Dermatol 2003;49:S78-86.
196. Morison WL, Momtaz-T K, Parrish JA. Combined methotrexate-PUVA therapy in the treatment of psoriasis. J Am Acad Dermatol 1982;6:46-51.
197. Petzelbauer P, Hönigsmann H, Langer K. Cyclosporin A in combination with photochemotherapy (PUVA) in the treatment of psoriasis. Br J Dermatol 1990;123:641-7.
198. Brazzelli V, Prestinari F, Chiesa MG, Borroni RG, Ardigo M, Borroni G. Sequential treatment of severe atopic dermatitis with cyclosporin A and low-dose narrow-band UVB phototherapy. Dermatology 2002;204:252-4.
199. Momtaz-T K, Parrish JA. Combination of psoralens and ultraviolet A and ultraviolet B in the treatment of psoriasis vulgaris: A bilateral comparison study. J Am Acad Dermatol 1984;10:481-6.
200. Ruzicka T, Sommerburg C, Braun-Falco O, Koster W, Lengen W, Lensing W. Efficiency of acitretin in combination with UVB in the treatment of severe psoriasis. Arch Dermatol 1990;126:482-6.
201. Iest J, Boer J. Combined treatment of psoriasis with acitretin and UVB phototherapy compared with acitretin alone and UVB alone. Br J Dermatol 1989;120:665-70.
202. Lauharanta J, Geiger JM. A double-blind comparison of acitretin and etretinate in combination with bath PUVA in the treatment of extensive psoriasis. Br J Dermatol 1989;121:107-12.
203. Tanew A, Guggenbichler A, Hönigsmann H, Geiger JM, Fritsch P. Photochemotherapy for severe psoriasis without or in combination with acitretin: a randomized, double-blind comparison study. J Am Acad Dermatol 1991;25: 682-4.
204. Saurat JH, Geiger JM, Amblard P, et al. Randomized double-blind multicenter study comparing acitretin-PUVA, etretinate-PUVA, and placebo-PUVA in the treatment of severe psoriasis. Dermatologica 1988;177:218-24.
205. Spuls P, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatolog Treat 2003;14(Suppl 2):17-20.
206. Green C, Lakshmipathi T, Johnson BE, Ferguson J. A comparison of the efficacy and relapse rates of narrowband UVB (TL-01) monotherapy vs etretinete (re-TL-01) vs etretinate-PUVA (re-PUVA) in the treatment of psoriasis patients. Br J Dermatol 1992;127:5-9.
207. Bavinck JN, Tieben LM, Van der Woude FJ, et al. Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal trasplant recipients: a double blind, placebo-controlled study. J Clin Oncol 1996;13:1933-8.
208. Nijsten TE, Stern RS. Oral retinoid use reduces cutaneous squamous cell carcinoma risk in patients with psoriasis treated with psoralen-UVA: a nested cohort study. J Am Acad Dermatol 2002;49:644-50.
209. Lebwohl M, Drake L, Menter A, et al. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol 2001;45:544-53.
210. Honigsmann H, Wolff K. Isotretinoin-PUVA for psoriasis. Lancet 1983;1:236.
211. Carlin CS, Callis KP, Krueger GG. Efficacy of acitretin and commercial tanning bed therapy for psoriasis. Arch Dermatol 2003;139:436-42.
212. Talper R, Ward S, Apisarnthanarax N, Breuer-McHan J, Duvic M. Optimizing bexrotene therapy for cutaneous T-cell lymphoma. J Am Acad Dermatol 2002;47:672-84.
213. McGinnis KS, Shapiro M, Vittorio CC, Rook AH, Junkins-Hopkins JM. Psoralen plus long-wave UV-A (PUVA) and bexarotene therapy: An effective and synergistic combined adjunct to therapy for patients with advanced cutaneous T-cell lymphoma. Arch Dermatol 2003;139:771-5.
214. Stern DK, Lebwohl M. Treatment of mycosis fungoides with oral bexarotene combined with PUVA. Drugs Dermatol 2002;1:134-6.
215. Ortel B, Perl S, Kinaciyan T, Calzavara-Pinton PG, Honigsmann H. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 1993;29:736-40.
216. Sakuntabhai A, Diffey BL, Farr PM. Response of psoriasis to psoralen-UVB photochemotherapy. Br J Dermatol 1993;128:296-300.
217. Carrascosa JM, Sabat M. Nuevas tendencias en la fototerapia del vitiligo. Piel 2002;17:97-100.
218. Hofer A, Kerl H, Wolf P. Long-term results in the treatment of vitiligo with oral khellin plus UVA. Eur J Dermatol 2001;11:225-9.
219. Njoo MD, Spuls PI, Bos JD. Nonsurgical repigmentation therapies in vitiligo. Arch Dermatol 1998;134:1532-40.
220. Ortel B, Tanew A, Hönigsmann H. Treatment of vitiligo with khellin and ultraviolet A. J Am Acad Dermatol 1988;18:693-701.
221. Antoniou C, Schulpis H, Michas T, et al. Vitiligo therapy with oral and topical pheniylalanine with UVA exposure. Int J Dermatol 1989;28:545-7.
222. Siddiqui AH, Stolk LML, Bhaggoe R, Hu R. Schutgens RBH, Westerhof W. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 1994;188:215-8.
223. Camacho F, Mazuecos J. Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience. Arch Dermatol 1999;135:216-7.
224. Whittaker SJ, Marsden JR, Spittle M, Russell Jones R. Joint British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous T-cell lymphomas. Br J Dermatol 2003;149:1095-107.
225. Roenigk HH Jr, Kuzel TM, Skotelis AP. Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma. J Invest Dermatol 1990;95:198S-205S.
226. Mostow EN, Neckel SL, Oberhelman L. Complete remission in psoralen and UVA (PUVA) refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA. Arch Dermatol 1993;129:38:9-11.
227. 12. Acta Derm Venereol 2002;82:485.
228. Middelkamp-Hup MA, Pathak MA, Parrado C, et al. Orally administered Polypodium leucotomos extract decreases psoralen-UVA-induced phototoxicity, pigmentation, and damage of human skin. J Am Acad Dermatol 2004;50:41-9.
229. Novak Z, Bonis B, Baltas E, et al. Xenon chloride ultraviolet B laser is more effective in treating psoriasis and in inducing T cell apoptosis than narrow-band ultraviolet B. J Photochem Photobiol B 2002;67:32-8.
230. Feldman SR, Mellen BG, Housman TS, Geronemus RG, Friedman PM, Vasily DB. Efficacy of the 308-nm excimer laser for treatment of psoriasis: results of a multicenter study. J Am Acad Dermatol 2002;46:900-6.
231. Trehan M, Taylor CR. Medium-dose 308 nm excimer laser for the treatment of psoriasis. J Am Acad Dermatol 2002;47:701-8.
232. Spann CT, Barbagallo J, Weinberg JM. A review of the 308-nm excimer laser in the treatment of psoriasis. Cutis 2001;68:351-2.
233. Spencer JM, Nossa R, Ajmeri J. Treatment of vitiligo with the 308-nm excimer laser: a pilot study. J Am Acad Dermatol 2002;46:727-31.
234. Baltas E, Nagy P, Bonis B, et al. Repigmentation of localizad vitiligo with the xenon chloride laser. Br J Dermatol 2001;144:1262-95.
235. Taneja A, Trehan M, Taylor CR. 308-nm excimer laser for the treatment of localized vitiligo. Int J Dermatol 2003;42:658-62.
236. Lotti TM, Menchini G, Andreassi L. UVB radiation microphototherapy. An elective treatment for segmental vitiligo. JEADV 1999;13:102-8.
237. Menchini G, Tsoureli-Nikita E, Hercogova J. Narrow-band UV-B micro-phototherapy: a new treatment for vitiligo. JEADV 2003;17:171-7.
238. Elman M, Slatkine M, Harth Y. The effective treatment of acne vulgaris by a high-intensity, narrow band 405-420 nm light source. J Cosmet Laser Ther 2003;5:111-7.
239. Kawada A, Aragane Y, Kameyama H, Sangen Y, Tezuka T. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation. J Dermatol Sci 2002;30:129-35.
240. Breuer-McHam J, Marshall M, Addu-Oppong A, et al. Alterations in HIV expression in AIDS patients with psoriasis or pruritus treated with phototherapy. J Am Acad Dermatol 1999;40:48-60.
241. Morison WL. PUVA therapy is preferable to UVB phototherapy in the management of HIV-associated dermatoses. Photochem Photobiol 1996;64:267-8.